Brokerages Set Arcus Biosciences, Inc. (NYSE:RCUS) Target Price at $30.25
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been assigned a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to […]
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been assigned a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to […]
